Last update 11 May 2025

Anti-CD20/CD22 CAR-T cell therapy (Yake Biotechnology)

Overview

Basic Info

Drug Type
CAR-T
Synonyms
AntiCD20/22 CART cell therapy Yake Biotechnology, CD20/CD22 dual Targeted CAR Tcell therapy Yake Biotechnology
Target
CD20 x CD22
Action
inhibitors
Mechanism
CD20 inhibitors(B-lymphocyte antigen CD20 inhibitors), CD22 inhibitors(CD22 inhibitors), Gene transference
Therapeutic Areas
NeoplasmsImmune System DiseasesHemic and Lymphatic Diseases
Active Indication
Hematologic NeoplasmsLymphoma
Inactive Indication-
Originator Organization
Shanghai Yake Biotechnology Co., LtdShanghai Yake Biotechnology Co., Ltd
Active Organization
Shanghai Yake Biotechnology Co., LtdShanghai Yake Biotechnology Co., Ltd
Inactive Organization-
License Organization-
Drug Highest PhaseEarly Phase 1
First Approval Date-
Regulation-
Login to view timeline

Related

2
Clinical Trials associated with Anti-CD20/CD22 CAR-T cell therapy (Yake Biotechnology)
ChiCTR1800020021
/ SuspendedNot ApplicableIIT
A single center, single arm, open labelled study for CD20\CD22 Dual Specificity CART Cell Therapy on Relapsed/Refractory B cell Lymphoma or Leukemia
NCT04283006
/ RecruitingEarly Phase 1
A Study of CD20/CD22 Targeted CAR T-cell Therapy for Relapsed or Refractory Lymphoid Malignancies
100 Clinical Results associated with Anti-CD20/CD22 CAR-T cell therapy (Yake Biotechnology)
Login to view more data
100 Translational Medicine associated with Anti-CD20/CD22 CAR-T cell therapy (Yake Biotechnology)
Login to view more data
100 Patents (Medical) associated with Anti-CD20/CD22 CAR-T cell therapy (Yake Biotechnology)
Login to view more data
100 Deals associated with Anti-CD20/CD22 CAR-T cell therapy (Yake Biotechnology)
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Hematologic NeoplasmsPhase 1
China
Shanghai Yake Biotechnology Co., LtdShanghai Yake Biotechnology Co., Ltd
23 May 2018
LymphomaPhase 1
China
Shanghai Yake Biotechnology Co., LtdShanghai Yake Biotechnology Co., Ltd
23 May 2018
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free